Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

William Perry (NPI 1033557418)

Field	Value
Entity Type	Individual
Organization	William Perry
Address	2751 Debarr Rd Ste B360
City	Anchorage
State	AK
ZIP	99508
Taxonomy	Diagnostic Radiology Physician
NPI Enumerated	June 7, 2013

Payer Source	Total Paid
Medicare	$811.7K
Medicaid	$0

Key Findings

This provider is effectively single‑payer: lifetime Medicare revenue is $811.7K and there is no Medicaid billing on file, so Medicare dominates the observable payer mix for this NPI. Analysts should treat all utilization and revenue patterns as Medicare-driven rather than balanced across payers.

Revenue is highly concentrated in a small set of nuclear medicine/PET services: the precomputed top three Medicare codes (78815, A9552, 78816) account for 71.3% of this provider's total Medicare revenue. In particular, 78815 alone contributes 47.7% of Medicare revenue, with A9552 at 12.6% and 78816 at 11.1%, indicating that PET imaging and its radiopharmaceutical supplies are the primary business drivers.

The code mix indicates a core PET/CT and radiopharmaceutical practice with supplementary cross‑sectional and vascular/interventional work. High‑revenue entries are PET/CT (78815, 78816) and radiotracer supply (A9552, A9596), while supporting services include CT of the abdomen/pelvis and thorax (74177, 71250, 71260), vascular/interventional procedures (37243, 36247), and a range of vascular ultrasound and line placement codes (93990, 93926, 36561, ), suggesting an operation that pairs advanced oncologic imaging with interventional radiology and access services.

On competitive standing for the core PET/CT work, 78815 ranks #757 of 6566 nationally (88th percentile; typical, unremarkable volume for this code), A9552 ranks #170 of 2411 (93th percentile; typical, unremarkable volume for this code), and 78816 ranks #386 of 1983 (80th percentile; typical, unremarkable volume for this code). These percentiles show above‑average national activity for the provider on key PET items but do not indicate a dominant national market leader—more an active, higher‑volume participant in PET services.

Several ancillary imaging and vascular codes also show relatively high national percentiles, highlighting breadth of services: 71250 (rank #2035 of 21854, 91th percentile; typical), 71260 (rank #2103 of 20343, 90th percentile; typical), 93990 (rank #101 of 1490, 93th percentile; typical), and 93926 (rank #174 of 4305, 96th percentile; typical). This pattern suggests the practice has comparatively strong activity in chest CT and vascular ultrasound/AV graft surveillance relative to national peers, reinforcing a hybrid diagnostics+procedural profile.

A few codes are relatively lower ranked nationally, indicating selective or less frequent use of certain services in the broader market: A9596 (rank #145 of 168, 14th percentile; typical, unremarkable volume for this code) and 70450 (rank #15029 of 21092, 28th percentile; typical, unremarkable volume for this code). The low percentile for A9596 (Gallium Ga‑68 gozetotide) implies this specific radiopharmaceutical is not a major revenue source compared with the provider's FDG PET work and may reflect limited utilization of that tracer or limited access relative to peers.

Operationally, the heavy reliance on PET/CT imaging and radiopharmaceuticals (top three codes = 71.3% of Medicare revenue) means the provider's revenue is sensitive to changes in PET tracer supply chains, reimbursement for PET/CT services, and shifts in oncology imaging utilization. Given the mix also includes interventional and vascular access codes, the practice retains some revenue diversity, but the PET concentration is the defining financial exposure.

The NPI has been enumerated since 2013-06-07 (~13 years ago), indicating over a decade of billing history; this tenure supports the interpretation that the observed PET/CT and interventional patterns are established components of the provider's service offering rather than a short‑term fluctuation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

63 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	260	$1,410	$365.3K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	310	$310	$96.4K
78816	The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The…	60	$1,390	$84.7K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	70	$790	$51.9K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	210	$120	$25.5K
71250	In this diagnostic procedure, the provider performs a computed tomography, or CT, examination of the thorax without using contrast material.	240	$100	$24K
71260	In this diagnostic procedure, the provider performs a computed tomography, or CT, examination of the thorax using contrast material.	180	$70	$12.8K
37243	The physician partially or completely blocks vascular blood flow in the target area for benign or malignant tumors (including uterine fibroids), organ ischemia, or infarction.	20	$590	$11.7K
36561	A central venous access catheter is a device that the physician inserts beneath the skin to draw blood or administer medication/nutrients to the patient. The catheter's tip must terminate in the…	30	$340	$9.1K
36558	The provider places a catheter, without a subcutaneous port or pump in one of the major veins carrying the blood to the heart or directly into the right atrium, to administer medication, nutrients,…	30	$250	$8.6K

Showing 1–10 of 63

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 63 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

William Perry — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

63 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9596	4	10	220	$830	$170.1K
78815	3	20	30	$1,000	$106.7K
78816	2	10	60	$1,050	$55.8K
77067	28	40	140	$80	$40.1K
A9552	2	10	30	$310	$34.1K
77063	23	40	130	$40	$18.3K
74177	16	60	80	$110	$15.5K
36561	4	20	20	$520	$12K
37243	1	10	20	$590	$11.7K
36558	3	10	30	$260	$7.9K

Showing 1–10 of 63

Related Providers

Other providers that share a Tax Identification Number (TIN) with William Perry, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bristol Bay Area Health Corporation	AK	Critical Access Hospital	$0	$37M
Bristol Bay Area Health Corporation	AK	General Practice Dentistry	$0	$9.1M
Bristol Bay Area Health Corporation	AK	Community/Behavioral Health Agency	$0	$6.8M
Alaska Imaging Associates, LLC	AK	Diagnostic Radiology Physician	$0	$3.8M
Steven Hake	CO	Diagnostic Radiology Physician	$982.7K	$0
Kamiar Massrour	AZ	Diagnostic Radiology Physician	$211.3K	$227.7K
Sarah Kelley	AK	Nurse Practitioner	$1.4K	$346.4K
Medical Park Family Care, LLC	AK	Family Medicine Physician	$0	$289.7K
Jose Ospina	CA	Diagnostic Radiology Physician	$170.4K	$110.1K
Bristol Bay Area Health Corporation	AK	Air Ambulance	$128.2K	$151.5K

William Perry — Billing Profile & Reimbursement Data

Sign up for William Perry — Billing Profile & Reimbursement Data policy alerts

William Perry — Billing Profile & Reimbursement Data

Sign up for William Perry — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Frequently Asked Questions

References